MET XL T 25

1. Specifications & All Details
Batch Number (B.No.): AMT2402
Manufacturing Date (MFG.DT.): 01/2024
Expiry Date (EXP.DT.): 12/2026
Maximum Retail Price (M.R.P.): Rs. 344.00 per 20 tablets (Inclusive of all taxes)
Drug Classification: SCHEDULE H PRESCRIPTION DRUG – CAUTION (Warning: Not to be sold by retail without the prescription of a Registered Medical Practitioner).
Manufacturing License Number (Mfg. Lic. No.): 14/UA/2022
Product Coding References: 3024157 and 9990102549248
2. General Information
Brand Name: Met XL-T 25
Generic Name: Telmisartan and Metoprolol Succinate Prolonged-release Tablets
Product Type: Prescription Cardiovascular Medication / Antihypertensive Combination
Form Factor: Solid, film-coated bilayered prolonged-release tablets
Quantity: 20 Tablets (indicated by the blister text “FOR 20 TABS”)
Maximum Shelf Life: 35 Months (From January 2024 to December 2026)
Food Preference / FSSAI: Not Applicable (This is a pharmaceutical medication under drug regulatory guidelines, not a dietary supplement or food item, so it does not contain an FSSAI layout or food preference markings).
3. Product Details (Ingredients)
Each film-coated bilayered tablet contains:
Telmisartan IP: 40 mg
Metoprolol Succinate IP: 23.75 mg (equivalent to Metoprolol Tartrate 25 mg as prolonged-release form)
Excipients: q.s. (Quantity Sufficient)
4. Directions & Storage
How to Use / Dosage: As directed by the Physician.
Administration Warning: The tablet must be swallowed whole and not to be broken, crushed or chewed.
Storage Instructions: Store below 30°C. Protect from light and moisture.
Handling Note: IMPORTANT: Moisture sensitive tablets – do not remove from strip until immediately before administration.
Pregnancy Warning: WARNING: When pregnancy is detected, Telmisartan should be discontinued as soon as possible as it can cause injury and even death to the developing foetus, when used in pregnancy during Second and Third Trimesters of Pregnancy.
5. Description
Product Overview: Met XL-T 25 is a prescription-strength combination cardiac therapy pairing an angiotensin II receptor blocker (Telmisartan, 40 mg) with a beta-blocker (Metoprolol Succinate, 23.75 mg). It features a specialized film-coated bilayered prolonged-release formulation designed to deliver a sustained antihypertensive effect.
Visual Appearance: The item is packaged in an Alu-Alu metallic silver blister strip featuring a micro-grid textured surface. The textual specifications are printed in distinct blue and black fonts, accompanied by bold red caution blocks emphasizing its prescription restriction. A white rectangular tracking sticker containing a scannable barcode is applied over the upper-left quadrant.
6. Manufacturer Information
Manufactured By: AEON FORMULATIONS PVT. LTD.
Plant Address: R.S. No. 515/1, 515/2 & 514, No. 152/7, Vinayagar Koli Street, Thirubhuvanai Palayam, Mannadipet Commune, Puducherry – 605 107.
7. Marketed By
Marketed By: ajanta pharma limited